Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002007162 | SCV002236420 | pathogenic | Nemaline myopathy 2 | 2022-11-01 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Asp3863Valfs*2) in the NEB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NEB are known to be pathogenic (PMID: 25205138). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with NEB-related conditions. ClinVar contains an entry for this variant (Variation ID: 1451228). |
Baylor Genetics | RCV004571700 | SCV005052094 | likely pathogenic | Arthrogryposis multiplex congenita 6 | 2024-02-19 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005025508 | SCV005650440 | likely pathogenic | Nemaline myopathy 2; Arthrogryposis multiplex congenita 6 | 2024-05-07 | criteria provided, single submitter | clinical testing |